Related Experiment Video
Updated: Mar 25, 2026

3D Cine Magnetic Resonance Imaging of Respiratory Motion in Mechanically Ventilated Mice and Rats
Published on: September 19, 2025
[Hypercapnic respiratory failure. Pathophysiology, indications for mechanical ventilation and management]
U Kreppein1, P Litterst1, M Westhoff2,3
1Abteilung für Pneumologie, Schlaf- und Beatmungsmedizin, Lungenklinik Hemer, Theo-Funccius-Str. 1, 58675, Hemer, Deutschland.
Non-invasive ventilation (NIV) is a primary treatment for hypercapnic respiratory failure, particularly in COPD and OHS patients. Close monitoring is crucial to identify when invasive ventilation or extracorporeal CO2 removal may be needed.
Area of Science:
- Pulmonary Medicine
- Critical Care
- Respiratory Physiology
Background:
- Acute hypercapnic respiratory failure commonly affects patients with Chronic Obstructive Pulmonary Disease (COPD) and Obesity Hypoventilation Syndrome (OHS).
- This condition can be associated with hypoxemic respiratory failure and presents significant challenges for mechanical ventilation management.
Purpose of the Study:
- To present current knowledge on the indications and management strategies for mechanical ventilation in patients experiencing hypercapnic respiratory failure.
- To review the literature concerning the optimal use of ventilation techniques for this patient population.
Main Methods:
- A comprehensive review of existing medical literature was conducted.
- The focus was on identifying and synthesizing information regarding mechanical ventilation in hypercapnic respiratory failure.
Main Results:
- Non-invasive ventilation (NIV) is the primary choice for hypercapnic respiratory failure with pH < 7.35, provided no contraindications exist.
- Careful patient selection, experienced teams, and close monitoring are essential for successful NIV, especially in severe respiratory acidosis.
- Ventilator settings for COPD exacerbations should prioritize long expiratory and short inspiratory times to prevent hyperinflation and intrinsic PEEP.
- Management must be tailored to the specific pathophysiology in OHS and overlap syndromes.
- Extracorporeal CO2 removal is a potential option for refractory cases, with emerging reports in awake patients.
Conclusions:
- NIV is the predominant treatment for hypercapnic respiratory failure, but vigilant monitoring is required to timely escalate to invasive ventilation if necessary.
- Further research and evaluation are needed for extracorporeal CO2 removal techniques, particularly in non-intubated patients.
Related Concept Videos
Acute Respiratory Failure-III
Mechanical Ventilation I: Indication and Settings
Acute Respiratory Failure-V
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Acute Respiratory Failure-I
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
Acute Respiratory Failure-II
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
Mechanical Ventilation II: Invasive Ventilation
Negative-Pressure Ventilators
Negative-pressure ventilators create a vacuum around the chest or body to draw air into the lungs, simulating breathing. This method does not require an...

